0000950170-24-010522.txt : 20240202 0000950170-24-010522.hdr.sgml : 20240202 20240202162156 ACCESSION NUMBER: 0000950170-24-010522 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240201 FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Amello Jason CENTRAL INDEX KEY: 0001451805 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 24591785 MAIL ADDRESS: STREET 1: 500 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 01824 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 ownership.xml 4 X0508 4 2024-02-01 0001783328 TScan Therapeutics, Inc. TCRX 0001451805 Amello Jason C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451 false true false false Chief Financial Officer false Stock Option (Right to Buy) 5.15 2024-02-01 4 A false 750000 0.00 A 2034-01-31 Voting Common Stock 750000 750000 D The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 29, 2024, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer. /s/ Zoran Zdraveski, Attorney-in-Fact 2024-02-02